• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by Can B Corp.

    1/13/25 10:58:14 AM ET
    $CANB
    Get the next $CANB alert in real time by email
    POS AM 1 formposam.htm

     

    As filed with the Securities and Exchange Commission on January 13, 2025

     

    Registration Statement No. 333-271908

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    POST-EFFECTIVE AMENDMENT

    TO

    FORM S-1

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

    CAN B CORP.

    (Name of small business issuer in our charter)

     

    Florida   0001509957   20-3624118

    (State or other jurisdiction

    of incorporation or organization)

     

    (Primary Standard Industrial

    Classification Code Number)

     

    IRS Employer

    Identification Number

     

    960 South Broadway, Suite 120

    Hicksville, NY

      11801
     (Address of principal executive offices)   (Zip Code)

     

    Telephone: (516) 595-9544

     

    Marco Alfonsi, CEO

    960 South Broadway, Suite 120

    Hicksville, NY 11801

    Telephone: (516) 595-9544

    (Name, address and telephone number of agent for service)

     

    Copies to:

     

    Philip D. Forlenza, Esq.

    Giordano, Halleran & Ciesla, P.C.

    125 Half Mile Road, Suite 300

    Red Bank, New Jersey 07701

    (732) 741-3900

     

    Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement, as determined by market conditions.

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act Registration Statement number of the earlier effective Registration Statement for the same offering. ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.

     

    Large accelerated filer ☐ Accelerated Filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
        Emerging growth company ☐

     

     

     

     

     

     

    REMOVAL OF SECURITIES FROM REGISTRATION

     

    Can B Corp. (the “Company”) previously registered for resale, under a Registration Statement on Form S-1 (Registration No. 333-271908), 6,760,336 shares of its Common Stock (the “Shares”) to be offered by the selling securityholder named in the Registration Statement. Each of the Shares has been converted into a share of Common Stock of Nascent Pharma Holdings, Inc. in connection with a holding company reorganization that was completed in October 2024. As a result, none of the Shares remain outstanding and by filing this Post-Effective Amendment to the Registration Statement, the Company hereby removes from registration all of the Shares that remain unsold under the Registration Statement as of the date hereof. The Registration Statement is hereby amended, as appropriate, to reflect the removal from registration of such Shares.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant has duly caused this Registration Statement to be signed on our behalf by the undersigned, thereunto duly authorized, in New York, New York on January 10, 2025.

     

      Can B Corp.
    January 10, 2025    
      By: /s/ Marco Alfonsi
        Marco Alfonsi
        Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature   Title   Date
             
    /s/ Marco Alfonsi   Chief Executive Officer, Director and Chairman   January 10, 2025
    Marco Alfonsi   (Principal Executive Officer)    
             
    /s/ Stanley L. Teeple   Secretary, CFO and Director   January 10, 2025
    Stanley L. Teeple   (Principal Financial and Accounting Officer)    
             
    /s/ Frederick Alger Boyer Jr.   Independent Director   January 10, 2025
    Frederick Alger Boyer Jr.        
             
    /s/ James Murphy   Independent Director   January 10, 2025

     

     

    Get the next $CANB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CANB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CANB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company

    Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") today announced that it has implemented a reorganization in which a new holding company, Nascent Pharma Holdings, Inc., has become the publicly-traded parent of Can B and its subsidiaries.  As a result of the reorganization, existing shares of Can B stock have been automatically converted, on a one-for-one basis, into shares of common stock of Nascent Pharma Holdings, Inc.  The Board and executive officers of Can B will continue in the same roles at Nascent Pharma Holdings, Inc. In March 2024, Can B announced that

    10/30/24 8:00:00 AM ET
    $CANB

    Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange

    HICKSVILLE, NY, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and durable medical devices, is pleased to announce it has successfully completed a corporate debt restructuring. Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024.  Specifically, three Promissory Notes issued to three funds in early 2022 and three Promissory Notes issued to three private investors in late 2022 were restructur

    3/15/23 11:49:00 AM ET
    $CANB

    Forever Brands Signs Manufacturing Agreement with Imbibe Wellness Solutions, LLC, a wholly owned subsidiary of Can B Corp for the Production of a new Plant Based Super Food Brand, Longevity by Brooke Burke Body TM.

    NEW YORK , July 26, 2022 /PRNewswire/ -- Forever Brands, a wholly owned subsidiary of ZA Group, Inc (OTCQB:ZAAG), has signed a manufacturing agreement with Imbibe Wellness Solutions, LLC a wholly owned subsidiary of Can B Corp (OTCQB:CANB) for the production of a new brand of Plant Based Super Food, Longevity by Brooke Burke Body TM. Can B develops consumer products at their State-of-the-Art-Research & Development facility in Lacey, WA. The Company develops, produces and test all products under the highest industry standards with independent lab testing. Can B issues Certificates of Analysis for all products! "This is a major milestone in our plan for launching Longevity on schedule. Securin

    7/26/22 8:00:00 AM ET
    $CANB

    $CANB
    SEC Filings

    View All

    SEC Form 15-12G filed by Can B Corp.

    15-12G - Can B Corp (0001509957) (Filer)

    7/16/25 11:16:04 AM ET
    $CANB

    SEC Form NT 10-K filed by Can B Corp.

    NT 10-K - Can B Corp (0001509957) (Filer)

    3/28/25 3:43:51 PM ET
    $CANB

    SEC Form EFFECT filed by Can B Corp.

    EFFECT - Can B Corp (0001509957) (Filer)

    1/27/25 12:15:04 AM ET
    $CANB

    $CANB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Can B Corp.

    SC 13G/A - Can B Corp (0001509957) (Subject)

    11/14/24 1:37:09 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 4:38:08 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 11:52:26 AM ET
    $CANB